Helena Bioinformatics

Sofia, Bulgaria All Bulgaria companies → — Founded 2026

AI Research Lab Point-of-Care Diagnostics Specialty-Focused AI

Family Medicine Internal Medicine Laboratory Medicine Oncology

Drug Discovery & Research Lab & Diagnostics

Seed (currently seeking financing for validation and European deployment) — No funding announced yet; product and evidence program are founder-financed.

Website Claim this company

Products

Noodle Biomedical Literature Discovery

Helena Bioinformatics

Drug Discovery & Research

Noodle is a biomedical literature discovery platform that allows researchers to search publications by meaning, inspect paper details, and explore related evidence through citation connections and semantic neighborhoods. It offers a public read-only Model Context Protocol (MCP) interface for AI agents.

Free

Folklore Clinical Variant Interpretation

Helena Bioinformatics

Lab & Diagnostics

Folklore is a clinical variant interpretation platform for genetic laboratories and researchers that brings genomic annotation, ACMG/AMP classification, phenotype and inheritance evidence, literature, and structured reporting into one traceable workflow.

Freemium

See all 2 products →

About Helena Bioinformatics

Helena Bioinformatics is a healthcare AI company based in Sofia, Bulgaria, specializing in software for genomic variant interpretation and biomedical literature discovery. Their flagship product, Folklore Clinical Variant Interpretation, streamlines the process for qualified genetics professionals by providing variant annotation, automated ACMG/AMP classification, source-linked evidence, and comprehensive reporting. This system is designed to transform raw genomic data into actionable clinical insights, supporting professional review rather than autonomous diagnostic or treatment decisions.

Complementing Folklore is Noodle Biomedical Literature Discovery, a tool that facilitates publication searches and explores citation and semantic connections between scientific papers. Both products are designed to assist research and laboratory teams in navigating genomic findings and the extensive literature that informs their review. Helena Bioinformatics emphasizes building secure, auditable infrastructure for clinical genomics, with AI operating within a controlled environment and processing sensitive genomic information on European infrastructure.

For physicians, Helena Bioinformatics’ offerings aim to enhance the efficiency and accuracy of genomic interpretation in clinical practice. The Folklore platform integrates various crucial pieces of information—annotation, deterministic classification, phenotype, inheritance, and literature evidence—into a single case record for specialist review. This approach is particularly valuable for medical genetics laboratories and rare-disease teams, enabling them to process and interpret whole-exome (WES) or whole-genome sequencing (WGS) cases more effectively. The company also focuses on developing methodologies for deterministic variant classification, structural variation, and agentic interpretation, contributing to the scientific understanding of how genomic evidence is handled and presented for clinical review.

Focus Areas

Bioinformatics Genomics Clinical software Biomedical research Genomic variant interpretation Biomedical literature discovery AI in healthcare

Business Intelligence

Key Investors	Founder-financed (initially), seeking external financing
Partnerships	CellGenetics, ELTA 90, Faculty of Biology at Sofia University, Institute of Information and Communication Technologies - Bulgarian Academy of Sciences (IICT-BAS), Bulgarian Association for Intelligent Systems (BAIS), Bulgarian Society of Robotics (BSR)
Technology	Cloud-native (EU-based processing), AI operating system (public read-only MCP interfaces for compatible AI agents), deterministic variant classification, evidence handling, phenotype-driven prioritization

What Physicians Need to Know

Bioinformatics & Genomics

Helena Bioinformatics specializes in genomic variant interpretation, offering software like 'Folklore Clinical Variant Interpretation' for automated ACMG/AMP classification, variant annotation, and source-linked evidence. They also develop computational methods for deterministic variant classification, structural variation, and agentic interpretation, contributing to publications and technical documentation. Their work addresses how genomic evidence is admitted, classified, prioritized, and presented for clinical review.

Clinical Software

Their flagship product, 'Folklore Clinical Variant Interpretation,' provides a workflow for qualified genetics professionals, integrating variant annotation, automated ACMG/AMP classification, and reporting. The software is designed to support research and professional review, rather than autonomous diagnosis or treatment decisions.

Biomedical Research & Literature Discovery

Helena Bioinformatics offers 'Noodle Biomedical Literature Discovery' for publication search and exploration of citation and semantic connections between papers, aiding research and laboratory teams in connecting genomic findings with relevant literature. They also engage in research partnerships to develop semantic models for integrating genomic, clinical, and laboratory information.

AI in Healthcare

Helena Bioinformatics develops advanced genomic technology with AI operating within a controlled environment, emphasizing European infrastructure and local processing of sensitive genomic information. They are involved in discussions with the European Commission on the responsible use of AI in healthcare and genomics, focusing on the human gate in pathogenicity decisions.

Key Differentiators

Helena Bioinformatics focuses on evidence-traceable software and infrastructure for clinical genomics. They emphasize deterministic variant classification, robust evidence handling, and phenotype-driven prioritization. Their approach ensures that AI assists in interpretation but the final pathogenicity decision is made by a human expert. They also prioritize secure, auditable infrastructure for clinical genomics with EU-based processing of sensitive genomic data.

Technology Stack

While specific programming languages and frameworks are not explicitly detailed, Helena Bioinformatics builds computational methods, genomic infrastructure, and clinical systems. Their work involves high-performance computing and clinical software engineering, with a focus on integrating genomic methodology from evidence treatment to laboratory review. They also utilize public read-only MCP interfaces for compatible AI agents.

Physician Tip

For physicians, Helena Bioinformatics offers tools that streamline genomic variant interpretation by providing automated classification, comprehensive annotation, and source-linked evidence within a single workflow. This can significantly reduce the time and effort required for reviewing genomic findings. The 'Noodle' platform assists in quickly finding and exploring relevant biomedical literature, enhancing the understanding of complex cases. Their emphasis on human oversight in AI-assisted interpretation ensures that clinical judgment remains central to diagnosis and treatment decisions. The secure, EU-based processing of genomic data also addresses concerns about data privacy and sovereignty.

Helena Bioinformatics collaborates with laboratories, universities, and research organizations to build scientific, clinical, and commercial foundations for genomic interpretation. They have partnerships for whole-genome sequencing analysis and interpretation for clinical diagnostics, as well as with distributors for laboratory technology. They are also involved in research partnerships for intelligent biomedical systems, AI methods, and data-driven decision support, including connecting genomic data with robotics and automation.

At a glance

Founded 2026

HQ Sofia, Bulgaria · Bulgaria

Team size The company currently operates with founder leadership, scientific governance, and external validation support, with plans to add clinical, regulatory, engineering, and commercial capacity with financing. One source indicates a headcount of 1.

CEO Vladimir Mitev

Funding Seed (currently seeking financing for validation and European deployment) — No funding announced yet; product and evidence program are founder-financed.

Products 2

Visit site

Products by Helena Bioinformatics

2 products in the directory

Noodle Biomedical Literature Discovery

Helena Bioinformatics

Drug Discovery & Research

Free

Folklore Clinical Variant Interpretation

Helena Bioinformatics

Lab & Diagnostics

Freemium

Reviews & Opinions

No web reviews on file yet for Helena Bioinformatics. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Helena Bioinformatics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Helena Bioinformatics →

View all on YouTube

Press & Coverage

Frontiers in Genetics

A Methodological Framework for Real-World Performance Studies of Clinical Variant Classification Platforms at Early Organizational Stages

This paper proposes a methodological framework for Real-World Performance Studies of automated platforms that classify sequence variants under the ACMG/AMP framework, demonstrating it on a variant classification platform developed by Helena Bioinformatics.

2026-08

Helena Bioinformatics Blog

Helena Bioinformatics and ELTA 90 Announce Exclusive Distribution Partnership in Bulgaria

Helena Bioinformatics has appointed ELTA 90 as its exclusive distribution partner in Bulgaria for Folklore, Helena's genomic interpretation platform, establishing a local commercial and implementation channel.

2026-08

Helena Bioinformatics Blog

Helena Bioinformatics Announces Three New Strategic Research Partnerships in Bulgaria

Helena Bioinformatics has entered into research cooperation agreements with the Department of Intelligent Systems at IICT-BAS, the Bulgarian Association for Intelligent Systems, and the Bulgarian Society of Robotics to strengthen genomics, AI, and engineering in Bulgaria.

2026-07

Helena Bioinformatics Blog

Helena Bioinformatics joins European Commission Discussion on the Future of AI in Healthcare

Helena Bioinformatics participated in a roundtable discussion with the European Commission to discuss the responsible use of artificial intelligence in healthcare, genomics, and biomedical research.

2026-07

ResearchGate

Neuro-symbolic AI for auditable cognitive information extraction from medical reports

This paper presents a neuro-symbolic AI that combines large language models with a rule-based expert system to reliably extract clinical data from diagnostic imaging reports, outperforming GPT-4 alone and matching physicians in accuracy.

2025-11

EU-Startups

Helena Bioinformatics | EU-Startups

Helena Bioinformatics, a Sofia-based software company, develops Folklore Clinical Variant Interpretation and Noodle Biomedical Literature Discovery, offering tools for genomic interpretation and biomedical research.

2023-03

Frequently Asked Questions

What specific bioinformatics and genomic services does Helena Bioinformatics offer that are relevant to clinical practice or healthcare administration?

Helena Bioinformatics provides solutions for genomic variant interpretation, leveraging AI to analyze complex genomic data for clinical decision support. Their offerings are designed to assist with precision medicine initiatives and the integration of genomic insights into patient care pathways.

How do Helena Bioinformatics' clinical software solutions integrate with existing electronic health record (EHR) systems and ensure data security and patient privacy (e.g., HIPAA compliance)?

Helena Bioinformatics' clinical software is designed with interoperability in mind, aiming for seamless integration with various EHR systems through standard APIs. They prioritize data security and are committed to maintaining compliance with regulations like HIPAA, employing robust encryption and access controls to protect patient information.

Can you explain Helena Bioinformatics' approach to AI in healthcare, particularly concerning the accuracy and validation of their genomic variant interpretation and biomedical literature discovery tools?

Helena Bioinformatics utilizes AI to enhance the accuracy and efficiency of genomic variant interpretation and biomedical literature discovery. Their AI models undergo rigorous validation processes, often involving collaborations with clinical experts and comparisons against established benchmarks, to ensure reliability and clinical utility.

What is the pricing model for Helena Bioinformatics' products and services, and what kind of technical support and training do you offer to healthcare providers and researchers?

Helena Bioinformatics offers flexible pricing models tailored to the specific needs of healthcare institutions and research facilities, which can include subscription-based or usage-based fees. They provide comprehensive technical support and training programs to ensure users can effectively utilize their software and interpret the generated insights.

What partnerships does Helena Bioinformatics have with other healthcare organizations, academic institutions, or research bodies, and how do these collaborations benefit their product development and clinical relevance?

Helena Bioinformatics actively collaborates with leading healthcare organizations, academic institutions, and research bodies to enrich their product development and ensure clinical relevance. These partnerships facilitate access to diverse datasets, clinical expertise, and real-world feedback, driving the continuous improvement and validation of their solutions.

What is the company's long-term vision and stability? How does Helena Bioinformatics plan to adapt to the evolving landscape of genomics and AI in healthcare?

Helena Bioinformatics is committed to long-term stability and continuous innovation in the rapidly evolving fields of genomics and AI in healthcare. Their vision includes ongoing research and development, strategic partnerships, and a focus on scalable, adaptable solutions to meet future challenges and opportunities in precision medicine.

How does Helena Bioinformatics address the challenges of integrating complex genomic data into routine clinical workflows for physicians and administrators?

Helena Bioinformatics addresses this by designing user-friendly interfaces and developing tools that distill complex genomic data into actionable insights relevant to clinical decision-making. They also focus on providing educational resources and support to help healthcare professionals effectively incorporate genomic information into their daily practice.

Related Companies

Suggest an Edit →